KR950032111A - 당 알콜의 신규한 황산 에스테르 - Google Patents
당 알콜의 신규한 황산 에스테르 Download PDFInfo
- Publication number
- KR950032111A KR950032111A KR1019950000506A KR19950000506A KR950032111A KR 950032111 A KR950032111 A KR 950032111A KR 1019950000506 A KR1019950000506 A KR 1019950000506A KR 19950000506 A KR19950000506 A KR 19950000506A KR 950032111 A KR950032111 A KR 950032111A
- Authority
- KR
- South Korea
- Prior art keywords
- sulfo
- penta
- sodium salt
- bis
- glucit
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/57—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
- C07C323/58—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
- C07C323/59—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton with acylated amino groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C305/00—Esters of sulfuric acids
- C07C305/02—Esters of sulfuric acids having oxygen atoms of sulfate groups bound to acyclic carbon atoms of a carbon skeleton
- C07C305/04—Esters of sulfuric acids having oxygen atoms of sulfate groups bound to acyclic carbon atoms of a carbon skeleton being acyclic and saturated
- C07C305/10—Esters of sulfuric acids having oxygen atoms of sulfate groups bound to acyclic carbon atoms of a carbon skeleton being acyclic and saturated being further substituted by singly-bound oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C305/00—Esters of sulfuric acids
- C07C305/02—Esters of sulfuric acids having oxygen atoms of sulfate groups bound to acyclic carbon atoms of a carbon skeleton
- C07C305/04—Esters of sulfuric acids having oxygen atoms of sulfate groups bound to acyclic carbon atoms of a carbon skeleton being acyclic and saturated
- C07C305/06—Hydrogenosulfates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
- C07C311/17—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/16—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C317/22—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C317/32—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C317/34—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring
- C07C317/36—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring with the nitrogen atoms of the amino groups bound to hydrogen atoms or to carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C335/04—Derivatives of thiourea
- C07C335/16—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
- C07D311/82—Xanthenes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Vascular Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Epoxy Compounds (AREA)
- Pyrane Compounds (AREA)
- Steroid Compounds (AREA)
- Laser Surgery Devices (AREA)
- Seasonings (AREA)
Abstract
본 발명은 하기 일반식 ( I ) 의 당 알콜 및 당 알콜-유사 화합물 및 그의 염의 신규한 황산 에스테르에 관한 것이다.
상기식에서, A는 하나 이상의 하이드록시 그룹이 황산으로 에스테르화된, 1-하이드록시 그룹이 없는 당 알콜 또는 이들의 유도체의 잔기이거나 또는 트리스-(하이드록시메틸)메틸 잔기이고; X는 -NR1CO-, -NHCONH-, -NHCSNH-, -NHSO2-, -NR1또는 -O-이고; m 및 p는 각각 독립적으로 O 또는 1이고; R1은 수소, 저급-알킬 또는 하이드록시-저급-알킬이며; B는 공액화된 다중 결합 시스템이다.
또한 본 발명은 일반식 (I)의 화합물 또는 그의 염을 함유하는 약학 제제; 특히 혈관 벽에서의 동맥경화성변화의 치료 및/또는 예방(예 : 관상 또는 말단 혈관성형술 또는 보조 수술 후의 재발협착증의 예방)을 위한 약제로서의 일반식 (I)의 화합물 및 그의 염의 용도; 일반식 (I )의 화합물 및 그의 염의 제조 방법 뿐만 아니라 상기 징후를 위한 약제의 제조에 관한 것이다.
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (10)
- 하기 일반식 (I)의 화합물 및 그의 염 :상기식에서, A는 하나 이상의 하이드록시 그룹이 황산으로 에스테르화된, 1-하이드록시 그룹이 없는 당 알콜 또는 이들의 유도체의 잔기이거나 또는 트리스-(하이드록시메틸)메틸 잔기이고; X는 -NR1CO-, -NHCONH-, -NHCSNH-, -NHSO2-, -NR1또는 -O-이고; m 및 p는 각각 독립적으로 0 또는 1이고; R1은 수소, 저급-알킬 또는 하이드록시-저급-알킬이며; B는 공액화된 다중 결합 시스템이다.
- 제1항에 있어서, X가 -NR1CO-, -NHCONH-, -NHCSNH-, -NHSO2-또는 -O-이고; B가 공액화된 이중 결합 시스템인 화합물 및 그의 염.
- 제1항에 있어서, A가 -(CHR2)nCH2R2이고, n은 1 내지 5의 정수이고, R2는 H, -OSO3H 또는 OZ이고, Z가 보호그룹이고, 적어도 하나의 잔기 R2가 -OSO3H인 화합물.
- 제1항 내지 제3항 중 어느 한 항에 있어서, 상기 공액화된 다중 결합 시스템 B가 2 내지 8개의 공액화된 다중 결합을 지닌 폴리엔 또는 폴리린 탄화수소 잔기인 화합물.
- 제1항 내지 제4항 중 어느 한 항에 있어서, 상기 공액화된 다중 결합 시스템 B가 공액화된 이중 결합의 시스템인 화합물.
- 제5항에 있어서, 상기 공액화된 이중 결합 시스템이 방향족 고리 시스템인 화합물.
- 제6항에 있어서, 상기 방향족 고리 시스템이 페닐렌; 저급-알킬 치환된 페닐렌; 나프틸렌, 플루오레닐렌; 또는 하기 일반식 (a) 내지 (s)중 하나의 잔기인 화합물 :상기식에서, Y는 탄소-탄소 결합, -O-, -CO-, -CH2-, -CH2-CH2-, -C≡C-, -CH(O)CH-, -CH=CH-, -SO2-, -C(CF3)2-, -CONR1-, -NHC0NH-, -NHCOCONH-, 페닐렌 또는 페닐렌디옥시이고; R1은 수소, 저급-알킬 또는 하이드록시-저급-알킬이고; R3및 R4는 수소, 저급-알킬, 저급-알콕시, 할로겐 또는 -SO3H이고; R5는 저급-알콕시-저급-알콕시, 페녹시 또는 할로겐에 의해 치환된 페녹시이고; R6은 수소 또는 SO5H이고; D는 -CH2CH2- 또는 -CH=CH-이며; V는 -CH=CH-, -CH2CH2- 또는 단일 결합을 의미한다.
- (Z)-부텐디오산(Z)-〔3-비페닐-4-일옥시메틸-5-〔3-(2,3,4,5,6-펜타-O-설포-D-글루시트-1-일카바모일)-아크릴로일아미노〕-페닐아미드〕-(2,3,4,5,6-펜타-O-설포-D-글루시트-1-일)-아미드 10나트륨 염, (E)-2-클로로스틸벤-4,4′-디카복실산 비스-(2,3,4,5,6-펜타-O-설포-D-글루시트-1-일아미드) 10나트륨 염, (Z)-스틸벤-4,4′-디카복실산 비스-(2,3,4,5,6-펜타-O-설포-D-글루시트-1-일아미드) 10나트륨 염,(2E,4E,6E,8E,1OE,12E,14E)-2,6,11,15-테트라메틸-헥사데카-2,4,6,8,10,12,14-헵타엔디카복실산 비스-(2,3,4,5,6-펜타-O-설포-D-글루시트-1-일아미드) 1O나트륨 염,4,4′-에틸렌-디벤조산 비스-(2,3,4,5,6-펜타-O-설포-D-글루시트-1-일아미드) 1O 나트륨 염, 3,3′-비스-(2,3,4,5,6-펜타-O-설포-D-글루시트-1-일)-1,1′-톨루엔-2,6-디일)-디우레아 1O 나트륨 염, 4,4′-비스-(2,3,4,5,6-펜타-O-설포-D-글루시트-1-일아미노)-3,3′-디니트로-N,N′-(4,4′-메틸렌-디페닐)-디벤즈아미드 10나트륨 염. N,N′-비스-(2,3,4,5,6-펜타-O-설포-D-글루시트-l-일)-2,2′-디니트로-4,4′-설포닐디아닐린 10나트륨 염, (Z)-스틸벤-4,4′-디카복실산 비스-(2,3,4,5,6-펜타-O-설포-L-람니트-1-일아미드) 8나트륨 염, 나프탈렌-1,5-디설폰산 비스-(2,3,4,5, 6-펜타-0-설포-D-글루시트-1-일아미드) 1O 나트륨 염, N,N′-비스-〔4-(2,3,4,5-테트라-O-설포-D-아라비니트-1-일옥시)-페닐〕-이소프탈아미드 8나트륨 염, 1,3-비스- 〔4-〔2,3,4,5,6-펜타-O-설포-D-갈락티트-6-일옥시)-페닐〕-우레아 10나트륨 염, N,N′-비스-〔4-〔3-(2,3,4,5,6-펜타-O-설포-D-글루시트-1-일)-우레이도〕-페닐〕-이소프탈아미드 10나트륨 염, 9-옥소-9H-플루오렌-2,7-디카복실산 비스-〔메틸-(2,3,4,5,6-펜타-O-설포-D-글루시트-1-일)아미드〕 10나트륨 염, 4,4′-메틸렌-디벤조산 비스-(2,3,4,5,6-펜타-O-설포-D-글루시트-1-일아미드) 10나트륨 염, 나프탈렌-2,6-디카복실산 비스-(2,3.4,5,6-펜타-O-설포-D-글루시트-1-일아미드) 10나트륨 염, N.N′-비스-(2,3,4,5,6-펜타-O-설포-D-글루시트-1-일)-이소프탈아미드 10나트륨 염, N,N′-비스-〔4-〔3-(2,3,4,5,6-펜타-O-설포-D-글루시트-1-일)-우레이도〕-페닐〕-푸마르아미드 1O나트륨 염, 4,4′-설포닐-디벤조산 비스-(2,3,4,5,6-펜타 -O-설포-D-글루시트-1-일아미드) 10나트륨 염.
- 특히 혈관벽중 동맥경화성 변화의 치료 및/또는 예방을 위한, 제1항 내지 제8항 중 어느 한 항에 따른 화합물, 및 치료적으로 불활성인 담체를 함유하는 약제.
- 제1항 내지 제8항 중 어느 한 항에 따른 화합물의 상응하는 비-황산화된 화합물을 황산화제와 반응시킴을 포함하는 제1항 내지 제8항 중 어느 한 항에 따른 화합물의 제조 방법.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH11494 | 1994-01-14 | ||
CH114/94 | 1994-01-14 | ||
CH331594 | 1994-11-07 | ||
CH3315/94 | 1994-11-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR950032111A true KR950032111A (ko) | 1995-12-20 |
Family
ID=25683559
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019950000506A KR950032111A (ko) | 1994-01-14 | 1995-01-13 | 당 알콜의 신규한 황산 에스테르 |
Country Status (21)
Country | Link |
---|---|
US (1) | US5521160A (ko) |
EP (1) | EP0663391B1 (ko) |
JP (1) | JP2862489B2 (ko) |
KR (1) | KR950032111A (ko) |
CN (1) | CN1043349C (ko) |
AT (1) | ATE151416T1 (ko) |
AU (1) | AU685196B2 (ko) |
CA (1) | CA2139720A1 (ko) |
CZ (1) | CZ8395A3 (ko) |
DE (1) | DE59500162D1 (ko) |
DK (1) | DK0663391T3 (ko) |
ES (1) | ES2101583T3 (ko) |
FI (1) | FI950127A (ko) |
GR (1) | GR3024012T3 (ko) |
HU (1) | HUT72412A (ko) |
IL (1) | IL112284A (ko) |
NO (1) | NO302817B1 (ko) |
NZ (1) | NZ270316A (ko) |
RU (1) | RU2139854C1 (ko) |
TW (1) | TW308598B (ko) |
UA (1) | UA42696C2 (ko) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2174582A1 (en) * | 1995-05-05 | 1996-11-06 | Alexander Chucholowski | Sulphuric acid esters of amino-sugars |
TR199600329A2 (tr) * | 1995-05-05 | 1997-03-21 | Hoffmann La Roche | Seker alkollerin yeni sülfürik asit esterleri. |
US6624197B1 (en) | 1998-05-08 | 2003-09-23 | Calyx Therapeutics, Inc. | Diphenylethylene compounds |
US6245814B1 (en) | 1998-05-08 | 2001-06-12 | Calyx Therapeutics, Inc. | Diphenylethylene compounds |
US7105552B2 (en) | 1998-05-08 | 2006-09-12 | Theracos, Inc. | Heterocyclic analogs of diphenylethylene compounds |
US6331633B1 (en) | 1998-05-08 | 2001-12-18 | Calyx Therapeutics Inc. | Heterocyclic analogs of diphenylethylene compounds |
WO2000015214A1 (en) * | 1998-09-11 | 2000-03-23 | Ilexus Pty Limited | Fc RECEPTOR MODULATORS AND USES THEREOF |
US7407978B2 (en) * | 1999-04-06 | 2008-08-05 | Theracos, Inc. | Heterocyclic analogs of diphenylethylene compounds |
US20080108825A1 (en) * | 1999-11-08 | 2008-05-08 | Theracos, Inc. | Compounds for treatment of inflammation, diabetes and related disorders |
US20020002200A1 (en) * | 2000-02-04 | 2002-01-03 | Bishwagit Nag | Novel diphenylethylene compounds |
US6525093B1 (en) | 1999-11-08 | 2003-02-25 | Calyx Therapeutics Inc. | Compounds to treat diabetes and associated conditions |
US7323496B2 (en) * | 1999-11-08 | 2008-01-29 | Theracos, Inc. | Compounds for treatment of inflammation, diabetes and related disorders |
US20080103302A1 (en) * | 2000-02-04 | 2008-05-01 | Theracos, Inc. | Compounds for treatment of inflammation, diabetes and related disorders |
CA2434636A1 (en) * | 2001-01-16 | 2002-07-25 | Guilford Pharmaceuticals, Inc. | Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (adp-ribose) glycohydrolase, and methods for their use |
GB0228410D0 (en) | 2002-12-05 | 2003-01-08 | Glaxo Group Ltd | Novel Compounds |
JP4466373B2 (ja) * | 2002-12-11 | 2010-05-26 | 日産化学工業株式会社 | 新規なジアミノベンゼン誘導体、それを用いたポリイミド前駆体およびポリイミド、並びに液晶配向剤 |
JP6051998B2 (ja) | 2012-03-30 | 2016-12-27 | 日油株式会社 | マルチアーム型ポリエチレングリコール誘導体、その中間体及び製造方法 |
BR112014029365A2 (pt) * | 2012-05-22 | 2017-06-27 | Hoffmann La Roche | inibidores seletivos de células indiferenciadas |
CN110092737B (zh) * | 2018-01-31 | 2022-06-17 | 海思美域(深圳)科技有限公司 | 一种抗静电化合物、材料的表面处理方法及改性材料 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3734815A1 (de) * | 1987-10-14 | 1989-04-27 | Luitpold Werk Chem Pharm | Polyschwefelsaeureester von bis-aldonsaeureamiden und deren derivaten, verfahren zu ihrer herstellung und arzneimittel |
DE3734853A1 (de) * | 1987-10-14 | 1989-04-27 | Luitpold Werk Chem Pharm | Bis-aldonsaeureamide und verfahren zu ihrer herstellung |
US5298616A (en) * | 1990-10-03 | 1994-03-29 | Hoffmann-La Roche Inc. | Sulfated O-polysaccharide-trehaloses |
CA2061370A1 (en) * | 1991-03-13 | 1992-09-14 | Markus Hosang | Pharmaceutical preparations |
-
1994
- 1994-12-20 TW TW083111951A patent/TW308598B/zh active
-
1995
- 1995-01-04 US US08/368,519 patent/US5521160A/en not_active Expired - Fee Related
- 1995-01-06 CA CA002139720A patent/CA2139720A1/en not_active Abandoned
- 1995-01-09 HU HU9500052A patent/HUT72412A/hu unknown
- 1995-01-09 AT AT95100180T patent/ATE151416T1/de not_active IP Right Cessation
- 1995-01-09 IL IL11228495A patent/IL112284A/en not_active IP Right Cessation
- 1995-01-09 DE DE59500162T patent/DE59500162D1/de not_active Expired - Fee Related
- 1995-01-09 ES ES95100180T patent/ES2101583T3/es not_active Expired - Lifetime
- 1995-01-09 EP EP95100180A patent/EP0663391B1/de not_active Expired - Lifetime
- 1995-01-09 AU AU10106/95A patent/AU685196B2/en not_active Ceased
- 1995-01-09 DK DK95100180.9T patent/DK0663391T3/da active
- 1995-01-10 NZ NZ270316A patent/NZ270316A/en unknown
- 1995-01-11 CN CN95101166A patent/CN1043349C/zh not_active Expired - Fee Related
- 1995-01-11 FI FI950127A patent/FI950127A/fi unknown
- 1995-01-11 RU RU95100773A patent/RU2139854C1/ru active
- 1995-01-12 CZ CZ9583A patent/CZ8395A3/cs unknown
- 1995-01-13 KR KR1019950000506A patent/KR950032111A/ko not_active Application Discontinuation
- 1995-01-13 UA UA95018035A patent/UA42696C2/uk unknown
- 1995-01-13 NO NO950137A patent/NO302817B1/no not_active IP Right Cessation
- 1995-01-13 JP JP7003729A patent/JP2862489B2/ja not_active Expired - Lifetime
-
1997
- 1997-07-08 GR GR970401667T patent/GR3024012T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
NO950137L (no) | 1995-07-17 |
NO302817B1 (no) | 1998-04-27 |
ES2101583T3 (es) | 1997-07-01 |
CN1109889A (zh) | 1995-10-11 |
ATE151416T1 (de) | 1997-04-15 |
JP2862489B2 (ja) | 1999-03-03 |
AU685196B2 (en) | 1998-01-15 |
EP0663391A1 (de) | 1995-07-19 |
FI950127A (fi) | 1995-07-15 |
NZ270316A (en) | 1996-08-27 |
EP0663391B1 (de) | 1997-04-09 |
JPH07206803A (ja) | 1995-08-08 |
IL112284A (en) | 1998-10-30 |
RU2139854C1 (ru) | 1999-10-20 |
CZ8395A3 (en) | 1995-11-15 |
IL112284A0 (en) | 1995-03-30 |
HUT72412A (en) | 1996-04-29 |
CA2139720A1 (en) | 1995-07-15 |
DK0663391T3 (da) | 1997-10-20 |
UA42696C2 (uk) | 2001-11-15 |
GR3024012T3 (en) | 1997-10-31 |
TW308598B (ko) | 1997-06-21 |
RU95100773A (ru) | 1996-10-27 |
NO950137D0 (no) | 1995-01-13 |
CN1043349C (zh) | 1999-05-12 |
US5521160A (en) | 1996-05-28 |
DE59500162D1 (de) | 1997-05-15 |
AU1010695A (en) | 1995-07-27 |
FI950127A0 (fi) | 1995-01-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR950032111A (ko) | 당 알콜의 신규한 황산 에스테르 | |
CA1291165C (en) | Alkylsulfonamidophenylalkylamines | |
US4065584A (en) | Sulphur containing arylamine derivatives | |
ES533009A0 (es) | Un procedimiento para la preparacion de nuevos derivados de 8-cloro71,5-benzotiazepina. | |
GB2441032A (en) | Salts of perfluorinated sulfoacetic acids | |
EP0657422B1 (en) | Naphthyloxyacetic acid derivatives as PGE2 agonists and antagonists | |
HU9400466D0 (en) | Substituted benzoyl-guanidine derivatives, process for producing them, use of them for inhibiting cellular na+/h+ exchange and pharmaceutical and diagnostical compositions containing them | |
US4981873A (en) | Substituted sulphonamides, pharmaceuticals thereof and methods of using them | |
SU510999A3 (ru) | Способ получени (метоксиметил-фурилметил)6,7-бензоморфанов илиморфинанов | |
AU2004212887A1 (en) | Sulfonamide derivatives as PPAR modulators | |
US4117005A (en) | Inter-oxa-13,14-dihydro-9β-PGD1 compounds | |
UA44238C2 (uk) | Ортозаміщені похідні бензойної кислоти, спосіб їх одержання (варіанти), спосіб одержання фармацевтичної композиції | |
KR100250099B1 (ko) | 인체 호중구 엘라스타제 억제제로서의 페닐렌디알카노에이트의 방향족 에스테르 | |
FR2366270A1 (fr) | Nouveaux derives de benzenesulfonamide utiles comme herbicides et procede pour leur preparation | |
BG62067B2 (bg) | Нови естери на сулфонови киселини с хидроксикумарини,метод за получаването им и лекарствени средства,които ги съдържат | |
KR910004547A (ko) | 아미노프로판올 유도체와 그의 제조방법 및 그를 함유하는 약제조성물 | |
FI73206B (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara alkyltiofenoxipropylaminer. | |
US3878212A (en) | Blood sugar lowering sulfamoyl pyrimidines and asymmetrical carbon atom | |
EP0260655A2 (en) | Unsaturated fatty acid derivatives and their production | |
JP3774907B2 (ja) | ナフチルオキシ酢酸誘導体およびそれらを有効成分として含有する薬剤 | |
GB2062622A (en) | Aniline Derivatives | |
US4097496A (en) | Novel cyclopentane derivatives | |
Bullock | Antiprotozoal quinones. I. Synthesis of 2-hydrox [-3-alkyl-1, 4-naphthoquinones as potential coccidiostats | |
JPH06104664B2 (ja) | 置換チオフエン‐2‐スルホンアミド抗緑内障剤 | |
DE4021437A1 (de) | Azulenderivate, verfahren zu deren herstellung und diese enthaltende arzneimittel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |